Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pre-menopausal Breast Cancer × Alpelisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Neoplasm Metastasis 5 Recurrence 3 Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Pre-menopausal Breast Cancer 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Multiple Myeloma 1 Meningioma 1 Melanoma 1 Kidney Neoplasms 1 Head and Neck Squamous Cell Cancer 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ductal, Breast 1 Advanced or Metastatic ER+ Breast Cancer 1 Advanced and Selected Solid Tumors 1 Advanced Solid Tumors With an Alteration of the PIK3CA Gene 1 Advanced Solid Tumor 1 Acrocephalosyndactylia 1 3rd Line GIST 1

Interventions

NVP-BKM120 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02058381 2020-03-09

B-YOND

Novartis

Phase 1 Completed

Pre-menopausal Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡